Hemoteq AG of Würselen at COMPAMED 2019 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option
Manufacturers Service

Hemoteq AG

Adenauerstr. 15, 52146 Würselen
Telephone +49 2405 4550-0
Fax +49 2405 4550-12

This company is co-exhibitor of
Freudenberg Medical Europe GmbH

Hall map

COMPAMED 2019 hall map (Hall 8b): stand H01

Fairground map

COMPAMED 2019 fairground map: Hall 8b

Our range of products

Product categories

  • 01  Manufacturing of components
  • 01.05  Surface treatment
  • 01.05.03  Surface coating
  • 03  Services
  • 03.02  Consulting (services)
  • 03.02.07  Medical device approval
  • 03  Services
  • 03.04  Design and development
  • 03.04.01  Product design, product development

Our products

Product category: Surface coating, Medical device approval, Product design, product development, Assembly

Coatings with controlled drug delivery

In DDCP, the drug coating is one of the key components that define clinical efficacy and safety of your unique combination product. 

Our well-proven toolbox consists of various proprietary coating platforms and process know-how that can be applied, and customized, to virtually any device concept. These coatings reliably and precisely deliver a wide range of active pharmaceutical ingredients with a specified release profile that ensures optimal clinical performance.

We have extensive experience in customization and volume production of DDCP for the following applications:

• Drug-Eluting Stents

• Drug-Coated Balloons

• Drug Delivery Coatings of non-vascular implants

More Less

Product category: Surface coating, Medical device approval, Product design, product development, Assembly

Drug Coatings for Balloon Catheters

Drug-coated balloon (DCB) technology is opening up unforeseen options in vascular medicine. DCBs have become standard of care in peripheral vascular interventions and fpr the treatment of reoccluded coronary stents. We have achieved pioneering work when it comes to high-performance, low-dose balloon coatings by tailoring coating composition, excipient and process technology to optimally deliver the unique anti-restenotic drug Paclitaxel.

Many DCB concepts co-developed in collaboration with prestigious customers have been granted regulatory approval and are now successfully established in clinical routine. 

In pursuit of the perfect DCB, new generations of balloon coatings have entered advanced-stage development, aiming at further optimizing DCB performance in challenging interventions and ultimately improving patients´ quality of life.

More Less

Product category: Surface coating, Medical device approval, Product design, product development, Assembly

Drug-Eluting Stent Coatings

Drug-eluting stents (DES) have revolutionized interventional cardiology and the treatment of patients suffering from coronary artery disease. Numerous OEMs are using Hemoteq´s coronary DES coating expertise for their innovative DES product range. Our unsurpassed range of DES platforms - polymer-based, polymer-free and excipient based drug releasing coatings - is the ideal launching pad for advanced DES addressing unmet needs in coronary and peripheral vascular interventions.

More Less

About us

Company details

Innovating together
Hemoteq is a leading contract development and contract manufacturing organisation (CDMO) for device drug combination products (DDCP) and specialty coated medical devices and components.

We have a proven track record backed by two decades of 360 degree expertise in advanced coating design, product and process development, regulatory strategy and volume production of DDCP and specialty coated components.

Working with Hemoteq headquartered in Würselen, Germany, you get access to the global capabilities of the Freudenberg Medical group - an „innovation hub“ that enables strategic innovation at the confluence of medtech, pharma and biotech.

Hemoteq operations work in accordance with applicable standards such as ISO 13485:2016.

More Less